Explore ViiV Healthcare

I am a
  • HCP
  • person living with HIV
  • NGO or patient group
  • job seeker
  • member of the public
  • academia / entrepreneur
  • media
...looking for
  • information about VHC medicines
  • clinical data and insights on VHC medicines
  • Independent Medical Education
  • medicines in development
  • how VHC is advancing HIV treatment and care
...looking for
  • information about VHC medicines
  • information and support about living with HIV
  • how to report a side effect
  • news and stories from ViiV Healthcare
...looking for
  • funding / grants
  • ViiV Healthcare's approach to partnerships
  • how ViiV Healthcare works with NGOs
  • news and stories from ViiV Healthcare
  • connect with ViiV Healthcare's community
...looking for
  • job opportunities
  • information about ViiV Healthcare
  • ViiV Healthcare's office locations
  • news and stories from ViiV Healthcare
...looking for
  • who are ViiV Healthcare
  • corporate ethics & compliance
  • news and stories from ViiV Healthcare
...looking for
  • opportunities to partner with ViiV Healthcare
  • information on ViiV Healthcare's Innovation Unit
  • news and stories from ViiV Healthcare
...looking for
  • press releases
  • ViiV Healthcare's Leadership
  • news and stories from ViiV Healthcare

VOCABRIA

Vocabria (cabotegravir) is listed on the Australian Register of Therapeutic Goods (ARTG).

VOCABRIA is used to treat HIV infection in adults. VOCABRIA tablets contain cabotegravir, which belongs to a group of antiretroviral medicines called integrase inhibitors (INIs). VOCABRIA tablets are always given in combination with another antiretroviral medicine, rilpivirine, to treat HIV infection.

VOCABRIA tablets do not cure HIV infection; in combination with rilpivirine, they keep the amount of virus in your body at a low level.

Resources

For patients:

For HCPs:

Date of Preparation: February 2021. PM-AU-CBR-WCNT-210003